Garrison Bradford & Associates’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,468
Closed -$2.39M 61
2024
Q4
$2.39M Sell
6,468
-799
-11% -$334K 2.5% 13
2024
Q3
$3.78M Buy
7,267
+135
+2% +$72.1K 3.75% 8
2024
Q2
$3.87M Hold
7,132
3.97% 8
2024
Q1
$3.7M Sell
7,132
-3
-0% -$1.49K 3.81% 8
2023
Q4
$3.37M Sell
7,135
-586
-8% -$271K 3.71% 8
2023
Q3
$3.36M Buy
7,721
+463
+6% +$210K 3.97% 7
2023
Q2
$3.23M Buy
7,258
+1
+0% +$461 3.9% 7
2023
Q1
$3.34M Sell
7,257
-399
-5% -$190K 4.13% 7
2022
Q4
$3.93M Sell
7,656
-149
-2% -$75.7K 4.76% 6
2022
Q3
$3.54M Buy
7,805
+92
+1% +$44K 4.31% 6
2022
Q2
$3.72M Buy
7,713
+3
+0% +$1.48K 4.23% 6
2022
Q1
$3.79M Sell
7,710
-59
-0.8% -$27K 3.68% 8
2021
Q4
$3.6M Sell
7,769
-150
-2% -$63.1K 3.23% 8
2021
Q3
$2.95M Buy
7,919
+1
+0% +$380 3% 10
2021
Q2
$3.02M Sell
7,918
-199
-2% -$76K 3.14% 10
2021
Q1
$2.91M Buy
8,117
+961
+13% +$309K 3.25% 10
2020
Q4
$2.3M Buy
7,156
+3,421
+92% +$1.05M 2.8% 10
2020
Q3
$1M Buy
+3,735
New +$1M 1.41% 18

Other funds holding ELV

Garrison Bradford & Associates's ELV Position: Q1 2025 in Review

Garrison Bradford & Associates sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 6,468 shares — an estimated $2.39M sold.

Garrison Bradford & Associates first reported a position in ELV in Q3 2020 and held it in 18 quarters. The position peaked at $3.93M in Q4 2022. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Garrison Bradford & Associates reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Garrison Bradford & Associates sold 6,468 Elevance Health shares in Q1 2025, an estimated $2.39M.
  • Garrison Bradford & Associates first reported a position in Elevance Health in Q3 2020 and held it in 18 quarters.
  • Garrison Bradford & Associates's Elevance Health position peaked at $3.93M in Q4 2022.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Garrison Bradford & Associates's 13F filing for Q1 2025, filed 6 May 2025.